Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2005-08-20

Original market date: See footnote 1

1951-12-31

Product name:

PAPAVERINE HYDROCHLORIDE INJECTION USP

DIN:

00009881 Electronic product monograph is not available

Company: 

SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada  J4B 1E6

Class: 

Human

Dosage form(s):

Liquid

Route(s) of administration:

Subcutaneous,  Intravenous,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

24:12.92   MISCELLANEOUS VASODILATATING AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A03AD01  PAPAVERINE

Active ingredient group (AIG) number:See footnote 5

0107115001

List of active ingredient(s)
Active ingredient(s) Strength
PAPAVERINE HYDROCHLORIDE 65 MG / 2 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: